Disruption of the Cyp7b1 Gene in Rats Increases Secretion of Very Low Density Lipoproteins by Decreasing Low Density Lipoprotein Receptor on Plasma Membrane
Ontology highlight
ABSTRACT: Cytochrome P450, family 7, subfamily b, polypeptide 1(CYP7B1) is a widely expressed hydroxylase enzyme that may be involved in inactivation of sterols. Using transposon in zygotes, we have generated rats lacking Cyp7b1 expression. Homozygous mutant animals show absence of Cyp7b1 mRNA expression in liver, small intestine, adipose tissue and muscle. Elevated levels of 25-hidroxycholesterol were found in liver of mutant rats. A fat gavage test showed that postprandial hypertriglyceridemia was decreased in homozygotes lacking Cyp7b1 without changes in cholesterol, APOA1 and APOA4 contents of postprandial lipoproteins. In this experimental setting, gene expression analyses of those coding for proteins involved in HDL structure and metabolism revealed that only hepatic Abca1 mRNA expression was significantly decreased. A four-hour fasting had no impact on plasma lipids. However, after prolonged fasting, plasma triglyceride levels in the homozygous mutants were increased about 164 % of wild types. In agreement with this, an increased hepatic secretion of VLDL in fasting rats treated with tyloxapol and absence of low-density receptor protein on the surface of hepatocytes were observed. The decrease in LDLr was not due to decreased mRNA expression but to increased expression of its protease Psck9. These data indicate that CYP7B1 and its metabolite 25-hydroxycholesterol modulates the metabolism of VLDL in liver by decreasing its capture by LDL receptor. In agreement with this, an increased hepatic secretion of VLDL in fasting rats treated with tyloxapol and absence of low-density receptor protein on the surface of hepatocytes were observed. The decrease in LDLr was not due to decreased mRNA expression but to increased expression of its protease Psck9. These data indicate that CYP7B1 and its metabolite 25-hydroxycholesterol modulates the metabolism of VLDL in liver by decreasing its capture by LDL receptor. These observations were partially recovered by exogenous plasmid hydrodinamic injection
ORGANISM(S): Rattus norvegicus
PROVIDER: GSE267177 | GEO | 2025/12/31
REPOSITORIES: GEO
ACCESS DATA